Europe Apheresis Market worth $1.07 billion by 2031
The Report "Europe Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure [Donor, Therapeutic], Application [Plasmapheresis, Plateletpheresis, Leukapheresis], Technology [Centrifugation], End User-Forecast to 2031" is projected to grow from USD 0.78 billion in 2026 and to reach USD 1.07 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
Browse 200 market data Tables and 60 Figures spread through 250 Pages and in-depth TOC on "Europe Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure [Donor, Therapeutic], Application [Plasmapheresis, Plateletpheresis, Leukapheresis], Technology [Centrifugation], End User-Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-apheresis-market-236229899.html
Growth in the Europe apheresis market is driven by rising demand for source plasma from biopharmaceutical companies, surging demand for blood components, and favorable reimbursement for apheresis. Increasing investments from government bodies and leading players present a lucrative opportunity in the apheresis market. However, strict donor recruitment criteria are expected to restrain the European apheresis market during the forecast period.
Therapeutic apheresis is the fastest growing segment in the Europe apheresis market in 2025.
By procedure, the Europe apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. Among these, therapeutic apheresis is the fastest-growing segment in 2025. Therapeutic apheresis offers an effective treatment option for a wide range of medical conditions, including neurological disorders, renal diseases, leukemia, and metabolic disorders. As advancements in medical research continue to reveal the therapeutic benefits of apheresis in managing these diverse diseases, healthcare providers are increasingly incorporating therapeutic apheresis into their treatment protocols. The versatility of therapeutic apheresis in addressing various medical conditions positions it as a crucial therapeutic modality, thereby fueling its growth within the apheresis market.
By application, photopheresis is the fastest growing in the Europe apheresis market in 2025.
By application, The Europe apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications, including lipidpheresis, lymphapheresis, immunoadsorption, and stem cell collection. Among these, photopheresis is the fastest-growing segment in the European apheresis market in 2025, driven by the global increase in the prevalence of blood disorders, including conditions such as graft-versus-host disease (GVHD), cutaneous T-cell lymphoma (CTCL), and autoimmune hemolytic anemia. Photopheresis offers a highly effective treatment modality for these disorders, providing targeted and personalized therapy by selectively targeting pathogenic cells while preserving healthy cells. As awareness of the therapeutic benefits of photopheresis continues to spread among healthcare providers and patients, there's a growing inclination toward its adoption, driving demand for photopheresis procedures and fueling the growth of this segment in the apheresis market.
Hospitals and transfusion centers are the fastest growing end users of the Europe apheresis market in 2025.
By end user, the Europe apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users, including emergency medical service providers, acute care centers, and medical and academic institutes. Among these, hospitals and transfusion centers are the fastest-growing segment in the Europe apheresis market in 2025. These end users possess greater financial resources, enabling them to afford the high costs associated with centrifugation-based apheresis devices. These institutions have budgets allocated specifically for advanced medical equipment, including apheresis technology, as they prioritize providing cutting-edge treatments and services to their patients. This financial capability allows them to invest in state-of-the-art equipment without significant financial constraints, thereby driving the growth of this segment.
Germany dominates the global Europe apheresis market in 2025
Germany dominates the Europe apheresis market primarily due to its highly developed, well-funded healthcare system, a substantial disease burden, and a strong regulatory environment that favors advanced procedures. The country maintains a robust blood collection and transfusion network, in which plasmapheresis plays a crucial role in sourcing plasma, supporting a large domestic pharmaceutical industry that relies on plasma-derived medicinal products. Furthermore, Germany's favorable reimbursement policies for specialized procedures such as therapeutic plasma exchange and photopheresis encourage widespread adoption. Finally, the strong presence of major domestic manufacturers, such as Fresenius Kabi and B. Braun, ensures continuous investment and rapid integration of advanced, highly automated apheresis technologies, solidifying their leading revenue share in the region.
Key Players
Prominent players in the Europe apheresis market include, Terumo BCT, Inc. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Baxter International Inc. (US), Asahi Kasei Medical Co., Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Becton, Dickinson and Company (US), Bioelettronica S.r.l. (Italy), Infomed SA (Switzerland), Cytosorbents Corporation (US), Medicap clinic GmbH (Germany), Haier Biomedical (China), B. Braun Melsungen AG (Germany), Cerus Corporation (US), Kaneka Corporation (Japan), SB-Kawasumi Laboratories, Inc (Japan), Nikkiso Co., Ltd (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co., Ltd. (Japan), PuriBlood Medical (Taiwan), LMB Technologie GmbH (Germany), Beijing ZKSK Technology Co., Ltd. (China), Guangzhou Daji Medical Science and Technology Co. Ltd (China).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Apheresis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
